Gottlieb rebukes Nostrum's 300% price hike for generic antibiotic

A price hike of more than 300% by Nostrum Pharmaceuticals LLC (New Brunswick, N.J.) for a 65-year-old antibiotic met swift condemnation by FDA Commissioner Scott Gottlieb on Sept. 11.

Gottlieb said

Read the full 302 word article

User Sign In